Recombinant thymosin alpha-1 (GeneScience Pharmaceuticals)
重组胸腺素α1（金赛药业）
Report date: 2022/12/27 10:30:28
Base Information
Drug NameRecombinant thymosin alpha-1 (GeneScience Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A